{"@type": "dcat:Dataset", "accessLevel": "public", "bureauCode": ["009:30"], "contactPoint": {"@type": "vcard:Contact", "fn": "SAMHSA", "hasEmail": "mailto:SAMHSAInfo@samhsa.hhs.gov"}, "description": "Trends in the Use of Methadone, Buprenorphine, and Extended-release Naltrexone at Substance Abuse Treatment Facilities: 2003-2015 (Update)", "distribution": [{"@type": "dcat:Distribution", "description": "Visit the original government dataset for complete information, documentation, and data access.", "downloadURL": "https://www.samhsa.gov/data/report/trends-use-methadone-buprenorphine-and-extended-release-naltrexone-substance-abuse-treatment", "mediaType": "text/html", "title": "Official Government Data Source"}], "identifier": "https://healthdata.gov/api/views/yqi4-9twy", "issued": "2025-07-14", "keyword": ["medication-assisted-treatment", "methadone-buprenorphine", "opioid-use-disorder", "samhsa", "substance-abuse-treatment"], "landingPage": "https://healthdata.gov/d/yqi4-9twy", "modified": "2025-09-06", "programCode": ["009:061"], "publisher": {"@type": "org:Organization", "name": "Substance Abuse and Mental Health Services Administration"}, "theme": ["SAMHSA"], "title": "Trends in the Use of Methadone, Buprenorphine, and Extended-release Naltrexone at Substance Abuse Treatment Facilities: 2003-2015 (Update)"}